TIM-3 expression was also more pronounced in CD4+ and CD8+ T cells from Patients exhibiting a higher tumor grade (G3)compared to those with a lower tumor grade (p=0.010 and p=0.042) (42). This evidence concerns the gene CD8A and neoplasm.